UnitedHealth Group is a top dividend growth stock with strong financials and potential for 20%+ returns by 2026. Read more ...

UnitedHealth Group will host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024, beginning at 8:00 a.m. EST.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.23% of ...

UnitedHealth Group (UNH) closed at $606.79 in the latest trading session, marking a +0.16% move from the prior day. This change lagged the S&P 500's 0.57% gain on the day. On the other hand, the Dow ...

UnitedHealthcare overcomes challenges for long-term success, targets 13-16% earnings growth, presents buying opportunity with $700 price target by 2025.

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter ...

Mairs & Power, an investment advisor, released the “Mairs & Power Growth Fund” third quarter 2024 investor letter. A copy of ...

The U.S. Department of Justice and four state attorney generals filed an antitrust lawsuit against UnitedHealth Group on ...

Madison Sustainable Equity Fund highlighted stocks like UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter 2024 investor letter. UnitedHealth Group Incorporated (NYSE:UNH) is a ...

UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The stock has a market capitalization of $543.67 billion, a P/E ratio of 38.49, a price-to-earnings-growth ratio of 1 ...

In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other most promising healthcare stocks according to hedge funds. The healthcare ...

The agency argues the merger could lead to higher healthcare costs, particularly as Amedisys is a direct competitor to UnitedHealth’s LHC Group, which was acquired for $5.4 billion in 2022.